切换至 "中华医学电子期刊资源库"

中华疝和腹壁外科杂志(电子版) ›› 2020, Vol. 14 ›› Issue (04) : 331 -335. doi: 10.3877/cma.j.issn.1674-392X.2020.04.003

所属专题: 文献

综述

胃食管反流病的非药物治疗研究进展
魏雪1, 卢迪1, 郝建宇1,()   
  1. 1. 100020 首都医科大学附属北京朝阳医院消化内科
  • 收稿日期:2020-04-02 出版日期:2020-08-18
  • 通信作者: 郝建宇
  • 基金资助:
    北京市科技计划首都临床特色应用研究与成果推广(Z171100001017054)

New progress in non-drug therapy for gastroesophageal reflux disease

Xue Wei1, Di Lu1, Jianyu Hao1,()   

  1. 1. Department of Gastroenterology, Beijing Chaoyang Hospital, Capital Medical University, Chaoyang District, Beijing 100020, China
  • Received:2020-04-02 Published:2020-08-18
  • Corresponding author: Jianyu Hao
  • About author:
    Corresponding author: Hao Jianyu, Email:
引用本文:

魏雪, 卢迪, 郝建宇. 胃食管反流病的非药物治疗研究进展[J]. 中华疝和腹壁外科杂志(电子版), 2020, 14(04): 331-335.

Xue Wei, Di Lu, Jianyu Hao. New progress in non-drug therapy for gastroesophageal reflux disease[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2020, 14(04): 331-335.

胃食管反流病是消化系统常见疾病,其主要治疗方法为质子泵抑制剂等药物治疗。但质子泵抑制剂等药物治疗存在一定局限性,因此随着内镜及腹腔镜技术的发展,部分胃食管反流病患者可以选择接受内镜治疗或外科手术治疗。本文将对内镜下治疗技术(射频治疗、经口内镜下贲门缩窄术、抗反流黏膜切除术、内镜下胃底折叠术)及腹腔镜下胃底折叠术的研究进展进行综述。

Gastroesophageal reflux disease (GERD) is a common gastrointestinal disease, which major treatment is medication therapy, such as pump proton inhibitors (PPIs). However, PPIs are limited in GERD treatment. Therefore, with the development of endoscopic and laparoscopic techniques, patients with GERD can choose endoscopic therapies or surgeries to cure the disease. New progress in endoscopic therapies (radiofrequency therapies, peroral endoscopic cardial constriction, anti-reflux mucosectomy, endoscopic fundoplication) and laparoscopic fundoplication will be elaborated in this review.

[1]
El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review[J]. Gut, 2014, 63(6): 871-880.
[2]
Subramanian CR, Triadafilopoulos G. Refractory gastroesophageal reflux disease[J]. Gastroenterol Rep(Oxf), 2015, 3(1): 41-53.
[3]
El-Serag H, Becher A, Jones R. Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies[J]. Aliment Pharmacol Ther2010, 32(6): 720-737.
[4]
Ito T, Jensen RT. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium[J]. Curr Gastroenterol Rep, 2010, 12(6): 448-457.
[5]
Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis[J]. Clin Gastroenterol Hepatol, 2013, 11(5): 483-490.
[6]
Zirk-Sadowski J, Masoli JA, Delgado J, et al. Proton-pump inhibitors and long-term risk of community-acquired pneumonia in older adults[J]. J Am Geriatr Soc, 2018, 66(7): 1332-1338.
[7]
Hung YP, Lee JC, Tsai BY, et al. Risk factors of Clostridium difficile-associated diarrhea in hospitalized adults: Vary by hospitalized duration[J/OB]. J Microbiol Immunol Infect, 2019, S1684-1182(19)30088-X.
[8]
Fry LC, Mönkemüller K, Malfertheiner P. Systematic review: endoluminal therapy for gastro-oesophageal reflux disease: evidence from clinical trials[J]. Eur J Gastroenterol Hepatol, 2007, 19(12): 1125-1139.
[9]
Tam WC, Schoeman MN, Zhang Q, et al. Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease[J]. Gut, 2003, 52(4): 479-485.
[10]
Hummel K, Richards W. Endoscopic treatment of gastroesophageal reflux disease[J]. Surg Clin North Am, 2015, 95(3): 653-667.
[11]
Viswanath Y, Maguire N, Obuobi RB, et al. Endoscopic day case antireflux radiofrequency(Stretta) therapy improves quality of life and reduce proton pump inhibitor(PPI) dependency in patients with gastro-oesophageal reflux disease: a prospective study from a UK tertiary centre[J]. Frontline Gastroenterol, 2019, 10(2): 113-119.
[12]
Liu PP, Meng QQ, Lin H, et al. Radiofrequency ablation is safe and effective in the treatment of Chinese patients with gastroesophageal reflux disease: A single-center prospective study[J]. J Dig Dis, 2019, 20(5): 229-234.
[13]
Liang WT, Wang ZG, Wang F, et al. Long-term outcomes of patients with refractory gastroesophageal reflux disease following a minimally invasive endoscopic procedure: a prospective observational study[J]. BMC Gastroenterol, 2014, 14: 178.
[14]
Noar M, Squires P, Noar E, et al. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later[J]. Surg Endosc, 2014, 28(8): 2323-2333.
[15]
Kalapala R, Shah H, Nabi Z, et al. Treatment of gastroesophageal reflux disease using radiofrequency ablation(Stretta procedure): An interim analysis of a randomized trial[J]. Indian J Gastroenterol, 2017, 36(5): 337-342.
[16]
Coron E, Sebille V, Cadiot G, et al. Clinical trial: Radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients[J]. Aliment Pharmacol Ther, 2008, 28(9): 1147-1158.
[17]
He S, Xu F, Xiong X, et al. Stretta procedure versus proton pump inhibitors for the treatment of nonerosive reflux disease: A 6-month follow-up[J]. Medicine(Baltimore), 2020, 99(3): e18610.
[18]
Perry KA, Banerjee A, Melvin WS. Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis[J]. Surg Laparosc Endosc Percutan Tech, 2012, 22(4): 283-288.
[19]
Fass R, Cahn F, Scotti DJ, et al. Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease[J]. Surg Endosc, 2017, 31(12): 4865-4882.
[20]
Lipka S, Kumar A, Richter JE. No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2015, 13(6): 1058-1067. e1.
[21]
Triadafilopoulos G. Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux disease[J]. World J Gastroenterol, 2014, 20(24): 7730-7738.
[22]
Li X, Zhang XB, Hu HQ, et al. Effect and safety of peroral endoscopic cardial constriction for gastroesophageal reflux disease[J]. Chin Med J(Engl), 2017, 130(14): 1749-1750.
[23]
Hu HQ, Li HK, Xiong Y, et al. Peroral endoscopic cardial constriction in gastroesophageal reflux disease[J]. Medicine (Baltimore), 2018, 97(15): e0169.
[24]
Satodate H, Inoue H, Yoshida T, et al. Circumferential EMR of carcinoma arising in Barrett's esophagus: case report[J]. Gastrointest Endosc, 2003, 58(2): 288-292.
[25]
Patil G, Dalal A, Maydeo A. Feasibility and outcomes of anti-reflux mucosectomy for proton pump inhibitor dependent gastroesophageal reflux disease: First Indian study(with video)[J]. Dig Endosc, 2020, 32(5): 745-752.
[26]
Inoue H, Ito H, Ikeda H, et al. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study[J]. Annals of gastroenterology, 2014, 27(4): 346-351.
[27]
Sumi K, Inoue H, Kobayashi Y, et al. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases[J]. Dig Endosc, 2020, DOI: 10.1111/den.13727.
[28]
Trad KS, Barnes WE, Prevou ER, et al. The TEMPO Trial at 5 Years: Transoral Fundoplication(TIF 2.0) Is Safe, Durable, and Cost-effective[J]. Surg Innov, 2018, 25(2): 149-157.
[29]
Testoni PA, Testoni S, Distefano G, et al. Transoral incisionless fundoplication with EsophyX for gastroesophageal reflux disease: clinical efficacy is maintained up to 10 years[J]. Endosc Int Open, 2019, 7(5): E647-E654.
[30]
Zacherl J, Roy-Shapira A, Bonavina L, et al. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial[J]. Surg Endosc, 2015, 29(1): 220-229.
[31]
Kim HJ, Kwon CI, Kessler WR, et al. Long-term follow-up results of endoscopic treatment of gastroesophageal reflux disease with the MUSE endoscopic stapling device[J]. Surg Endosc, 2016, 30(8): 3402-3408.
[32]
Richards WO, Houston HL, Torquati A, et al. Paradigm shift in the management of gastroesophageal reflux disease[J]. Ann Surg, 2003, 237(5): 638-647.
[33]
Liang WT, Wu JM, Hu ZW, et al. Laparoscopic Nissen fundoplication is more effective in treating patients with GERD-related chronic cough than Stretta radiofrequency[J]. Minerva Chir, 2014, 69(3): 121-127.
[34]
Hu ZW, Wang ZG, Zhang Y, et al. A preliminary investigation of anti-reflux intervention for gastroesophageal reflux related childhood-to-adult persistent asthma[J]. Ann Surg Innov Res, 2014, 8: 3.
[35]
Liang WT, Wu JN, Wang F, et al. Five-year follow-up of a prospective study comparing laparoscopic Nissen fundoplication with Stretta radiofrequency for gastroesophageal reflux disease[J]. Minerva Chir, 2014, 69(4): 217-223.
[36]
Liang WT, Yan C, Wang ZG, et al. Early and Midterm outcome after laparoscopic fundoplication and a minimally invasive endoscopic procedure in patients with gastroesophageal reflux disease: a prospective observational Study[J]. J Laparoendosc Adv Surg Tech A, 2015, 25(8): 657-661.
[37]
Hu Z, Wu J, Wang Z, et al. Outcome of Stretta radiofrequency and fundoplication for GERD-related severe asthmatic symptoms[J]. Front Med, 2015, 9(4): 437-443.
[38]
Yan C, Liang WT, Wang ZG, et al. Comparison of Stretta procedure and toupet fundoplication for gastroesophageal reflux disease-related extra-esophageal symptoms[J]. World J Gastroenterol, 2015, 21(45): 12882-12887.
[39]
Zhang C, Wu J, Hu Z, et al. Diagnosis and anti-reflux therapy for gerd with respiratory symptoms: a study using multichannel intraluminal impedance-pH monitoring[J]. PLoS One, 2016, 11(8): e0160139.
[1] 贾卓奇, 周维茹, 张勇, 张广健, 付军科. 达·芬奇机器人与腹腔镜食管裂孔疝修补术的对比研究[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(04): 410-414.
[2] 李亮, 洪楚原, 李明哲, 郝腾飞, Chongkuo Zi. 胃食管结合部抗反流机制探讨[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(01): 6-8.
[3] 王擎, 王冠峰, 陈星. 胃食管阀瓣的Hill分级在胃食管反流病中的应用价值[J]. 中华胃肠内镜电子杂志, 2023, 10(02): 125-130.
[4] 张继舜, 陈思旭, 钱洁, 尚占民, 郝建宇. 平均夜间基线阻抗对食管外症状胃食管反流病的临床诊断价值[J]. 中华胃肠内镜电子杂志, 2023, 10(02): 97-102.
[5] 陆洪鹏, 袁芯, 郑树灏, 刘怡, 徐磊. 慢性咳嗽与胃食管反流病:双向两样本孟德尔随机化研究[J]. 中华胃食管反流病电子杂志, 2023, 10(02): 59-64.
[6] 范勇, 张利昉, 杨美琳. 改良经口内镜下贲门缩窄术治疗胃食管反流病效果分析[J]. 中华胃食管反流病电子杂志, 2023, 10(02): 65-68.
[7] 文明, 熊英, 艾克拜尔·艾力, 克力木·阿不都热依木. 质子泵抑制剂治疗期间焦虑对胃食管反流病疗效的影响[J]. 中华胃食管反流病电子杂志, 2023, 10(02): 90-95.
[8] 李鹏, 刘国祥, 李汝红. 经口内镜下贲门缩窄术治疗胃食管反流病的研究进展[J]. 中华胃食管反流病电子杂志, 2023, 10(02): 96-99.
[9] 买买提·依斯热依力, 尹强, 尹海龙, 董雨微, 王永康, 克力木·阿不都热依木, 阿吉艾克拜尔·艾萨. 传统医药治疗胃食管反流病的研究进展[J]. 中华胃食管反流病电子杂志, 2023, 10(02): 100-104.
[10] 闫晶, 蒋媛, 买买提·依斯热依力, 王俭, 王永康, 阿巴伯克力·乌斯曼, 王志, 克力木·阿不都热依木. 膈肌生物反馈训练对胃食管反流病的效果分析[J]. 中华胃食管反流病电子杂志, 2023, 10(01): 50-55.
[11] 张晓贝, 王伟刚, 李晓龙, 易风俊, 俞永江. 幽门螺旋杆菌感染与不同亚型胃食管反流病的相关性[J]. 中华胃食管反流病电子杂志, 2023, 10(01): 1-5.
[12] 张高松, 杨美琳, 袁莉, 俞炎波, 石琳妮. 内镜下贲门缩窄术对改善胃食管反流病患者生活质量的观察[J]. 中华胃食管反流病电子杂志, 2023, 10(01): 18-21.
[13] 李赞林, 马建惠, 王志. 腹腔镜袖状胃切除术对胃食管反流病疗效的系统评价与分析[J]. 中华胃食管反流病电子杂志, 2023, 10(01): 22-30.
[14] 石晓璐, 年媛媛, 孟宪梅. 胃食管反流病的内镜治疗[J]. 中华胃食管反流病电子杂志, 2023, 10(01): 38-41.
[15] 伍振鹏, 乔钰涵, 向林, 江云颂, 彭居正, 吴丽娜, 程吕佳, 关炳生, 庄子康, 杨景哥. 腹腔镜袖状胃切除术中胃窦切缘与幽门的距离对术后胃食管反流病及减重效果的影响[J]. 中华肥胖与代谢病电子杂志, 2023, 09(01): 4-11.
阅读次数
全文


摘要